RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. Founded by Ron Seubert in 2009RareCyte is backed by Agilent Technologies, F-Prime Capital, Logos Capital, Arboretum Ventures, and 5AM Ventures and is headquartered in Seattle.